NCT00003021View on ClinicalTrials.gov

Bizelesin in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1997

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bizelesin

Trial Locations (2)

78229

Cancer Therapy & Research Center, San Antonio

78234

Brooke Army Medical Center, Fort Sam Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00003021 - Bizelesin in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter